Tower Research Capital (TRC)’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Sell |
21,289
-7,182
| -25% | -$83.7K | 0.01% | 1589 |
|
|
2025
Q1 | $212K | Buy |
28,471
+27,791
| +4,087% | +$206K | 0.01% | 1338 |
|
|
2024
Q4 | $4.08K | Sell |
680
-15,111
| -96% | -$90.6K | ﹤0.01% | 4521 |
|
|
2024
Q3 | $80.9K | Buy |
15,791
+1,225
| +8% | +$6.27K | ﹤0.01% | 2394 |
|
|
2024
Q2 | $52.7K | Buy |
14,566
+13,384
| +1,132% | +$48.5K | ﹤0.01% | 3067 |
|
|
2024
Q1 | $3.79K | Sell |
1,182
-78,361
| -99% | -$252K | ﹤0.01% | 4792 |
|
|
2023
Q4 | $390K | Buy |
79,543
+69,431
| +687% | +$340K | ﹤0.01% | 1573 |
|
|
2023
Q3 | $55.1K | Sell |
10,112
-3,283
| -25% | -$17.9K | ﹤0.01% | 2463 |
|
|
2023
Q2 | $89.9K | Sell |
13,395
-25,583
| -66% | -$172K | ﹤0.01% | 2091 |
|
|
2023
Q1 | $344K | Buy |
38,978
+38,128
| +4,486% | +$336K | 0.01% | 1058 |
|
|
2022
Q4 | $6K | Sell |
850
-19,264
| -96% | -$136K | ﹤0.01% | 4675 |
|
|
2022
Q3 | $143K | Buy |
20,114
+16,369
| +437% | +$116K | ﹤0.01% | 2230 |
|
|
2022
Q2 | $30K | Sell |
3,745
-17,095
| -82% | -$137K | ﹤0.01% | 3364 |
|
|
2022
Q1 | $290K | Buy |
20,840
+20,026
| +2,460% | +$279K | ﹤0.01% | 1484 |
|
|
2021
Q4 | $23K | Sell |
814
-560
| -41% | -$15.8K | ﹤0.01% | 3496 |
|
|
2021
Q3 | $47K | Sell |
1,374
-7,734
| -85% | -$265K | ﹤0.01% | 3009 |
|
|
2021
Q2 | $372K | Buy |
9,108
+7,649
| +524% | +$312K | 0.01% | 1422 |
|
|
2021
Q1 | $59K | Sell |
1,459
-4,401
| -75% | -$178K | ﹤0.01% | 2976 |
|
|
2020
Q4 | $347K | Buy |
5,860
+4,886
| +502% | +$289K | 0.01% | 1284 |
|
|
2020
Q3 | $47K | Sell |
974
-632
| -39% | -$30.5K | ﹤0.01% | 3560 |
|
|
2020
Q2 | $78K | Buy |
+1,606
| New | +$78K | ﹤0.01% | 2671 |
|
|
2019
Q4 | – | Sell |
-54
| Closed | -$2K | – | 3450 |
|
|
2019
Q3 | $2K | Buy |
+54
| New | +$2K | ﹤0.01% | 3647 |
|